Trial intelligence / Profile preview

Alfuzosin for Sexual Function in BPH

NCT00427882Phase 4Completed

Sponsor
Handok
Start
Sep 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of alfuzosin in benign prostatic hyperplasia (BPH), sponsored by Handok. Started Sep 2006; status: completed.

02

Drugs

alfuzosin
03

Conditions

benign prostatic hyperplasia (BPH)

Beyond the preview

Go deeper on NCT00427882.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00427882.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call